Charta Health raises $55M: AI medical coding is now a capital race, and the key data sits in the medical record

By MobiHealthNews · November 10, 2026.

Charta Health, a San Francisco startup that uses AI to automate medical billing and coding, has closed a $55 million round, bringing its total funding to $85 million, MobiHealthNews reports. Insight Partners led the round, with participation from existing investors Madrona, Bain Capital Ventures and South Park Commons, as well as QuantumLight.

The round coincides with the launch of Charta for Payers, a suite of six AI products for insurers (the “payers”). The company's payer offering includes retrospective risk adjustment, an intelligent coding platform, automated second-level review of coded charts, RADV audit management (risk adjustment audits) and HEDIS quality analytics (a standard set of healthcare quality measures). According to the company, the funds will be used to launch Charta for Providers, its offering for care providers, and to expand the payer offering into new specialties.

The financial context helps gauge the pace. Charta raised $22 million in a Series A and $8.1 million in seed funding last year, according to the same source. This year it also reached an agreement with athenahealth to be distributed through its app marketplace.

It is not alone. According to the same outlet, Arintra raised $25 million in a Series B this year (total: $51 million) and Candid Health closed a $120 million Series D at a valuation that, according to the company, tripled that of its February 2025 Series C. CodaMetrix raised $40 million in 2024.

The most revealing quote comes from Jeff Horing of Insight Partners: the opportunity lies in getting the underlying record, the “ground truth,” right before the claim is submitted. Charta combines AI with client-specific coding expertise and serves both sides of the market.

Our take: the thesis is that the bottleneck in healthcare AI is not the model but data quality. An error in the medical record propagates to the bill, the audit and the risk adjustment. Whoever fixes it at the source captures value across the entire chain.

There is a tension worth naming. Charta sells to providers and insurers at the same time, and their interests clash on every claim. An AI that helps payers detect risk adjustments and another that helps providers uncover revenue could end up locked in a mutual automation arms race. The material offers no evidence of how Charta manages that conflict, and the funding round does not address it. Nor are there verified figures on accuracy or savings; everything said about effectiveness comes from the company itself or its investor.

As for jobs, this is the textbook example of an exposed back office: coding and chart review are administrative, repetitive, rules-based work. In the short term, predictably fewer routine positions and more roles in auditing, clinical judgment and model oversight. This is the hard transition we talk about, and it should not be sugarcoated.

Even so, the outlook is favorable. Part of healthcare spending is lost to administrative friction, not care. If AI reduces that friction honestly, and not merely as a weapon to optimize billing, it frees up resources and clinical time. It is a modest but useful step toward more abundant healthcare.

What to watch in the coming quarters: that results are measured independently, that human audits remain in place and that “autonomous coding” does not become a way to inflate diagnoses. That is the difference between efficiency and optimization at the system's expense.